Lily I Cheng

5PUBLICATIONS
83CO-AUTHORS
Tumour immunologyPredictive and prognostic markersMolecular targetsInnate immunityAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 24, 2023
Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma.

Julio C Chavez, Francine M Foss, Basem M William

|Dec 01, 2022
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Charu Aggarwal, Nabil F Saba, Alain Algazi

|Jan 25, 2022
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans.

Yueh-Ming Loo, Patrick M McTamney, Rosalinda H Arends

|Mar 06, 2021
PD-L1<sup>+</sup> neutrophils contribute to injury-induced infection susceptibility.

Ajitha Thanabalasuriar, Abby J Chiang, Christopher Morehouse

|Mar 09, 2018
T follicular helper-like cells contribute to skin fibrosis.

Devon K Taylor, Nanette Mittereder, Ellen Kuta

Pageof 1